Janet P Hapgood

6PUBLICATIONS
17CO-AUTHORS
ReproductionNanotoxicology, health and safetyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 05, 2026
Injectable contraceptives differentially affect the hypothalamic-pituitary-gonadal axis and amenorrhea incidence†.

Alexis J Bick, Chanel Avenant, Carole-Keza Capitaine

|May 11, 2025
Injectable Contraceptives Differentially Affect Select CD4+ HIV-1 Target Cells in the Genital Tract but Not Systemically: Implications for HIV-1 Acquisition.

Chanel Avenant, Alexis J Bick, Johnson M Moliki

|Aug 23, 2024
The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial.

Chanel Avenant, Mandisa Singata-Madliki, Alexis J Bick

|Dec 22, 2023
Misreporting contraceptive use and the association of peak study progestin levels with weight and BMI among women randomized to the progestin-only injectable contraceptives DMPA-IM and NET-EN.

Chanel Avenant, Alexis J Bick, Salndave B Skosana

|Oct 27, 2022
Increased HIV-1 infection in PBMCs treated in vitro with menstrual cycle phase hormones or medroxyprogesterone acetate likely occurs via different mechanisms.

Alexis J Bick, Chanel Avenant, Michele Tomasicchio

|Apr 27, 2018
Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levels.

Michelle F Maritz, Roslyn M Ray, Alexis J Bick

Pageof 1

Frequent Collaborators

3 joint publications

Alexis J Bick

3 joint publications

Chanel Avenant

2 joint publications

Michele Tomasicchio

2 joint publications

Karl-Heinz Storbeck